Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelodysplastic Syndrome MDS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07582172
What this trial is testing

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia With Complex KaryotypeMyelodysplastic Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+8 more
City of Hope Medical Center 35
Not applicableLooking for participantsNCT06411626
What this trial is testing

Home Reported Outcomes in PNH

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Novartis Pharmaceuticals 128
Early research (Phase 1)Study completedNCT00060372
What this trial is testing

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more
National Cancer Institute (NCI) 21
Early research (Phase 1)Study completedNCT05030675
What this trial is testing

Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents

Who this might be right for
Refractory Chronic Myelomonocytic LeukemiaRefractory Myelodysplastic Syndrome
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT01203722
What this trial is testing

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87
Testing effectiveness (Phase 2)Study completedNCT00689000
What this trial is testing

Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeMultiple Myeloma
Chroma Therapeutics 57
Large-scale testing (Phase 3)Study completedNCT00045292
What this trial is testing

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT02118311
What this trial is testing

Treg Cells for AGVHD in Non-myeloablative UCB Transplant

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota
Not applicableUnknownNCT03014934
What this trial is testing

Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation

Who this might be right for
Invasive Aspergillosis
European Society for Blood and Marrow Transplantation 2,100
Testing effectiveness (Phase 2)Study completedNCT00301834
What this trial is testing

Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders

Who this might be right for
Congenital Amegakaryocytic ThrombocytopeniaDiamond-blackfan AnemiaLeukemia+2 more
University of California, San Francisco 35
Testing effectiveness (Phase 2)Ended earlyNCT04752163
What this trial is testing

DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmRecurrent Acute Lymphoblastic LeukemiaRecurrent Acute Myeloid Leukemia+6 more
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Looking for participantsNCT06978699
What this trial is testing

A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Who this might be right for
PNH - Paroxysmal Nocturnal Hemoglobinuria
S-INFINITY Pharmaceuticals Co., Ltd 24
Testing effectiveness (Phase 2)Study completedNCT00109993
What this trial is testing

Campath-1H + FK506 and Methylprednisolone for GVHD

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Case Comprehensive Cancer Center 34
Not applicableLooking for participantsNCT06960993
What this trial is testing

Mosaic Trial for Stem Cell Transplant Recipients

Who this might be right for
Hematologic MalignancyStem Cell TransplantBone Marrow Transplant+4 more
Northwestern University 356
Testing effectiveness (Phase 2)Looking for participantsNCT06918834
What this trial is testing

Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients

Who this might be right for
Myelodysplastic Syndromes
Institute of Hematology & Blood Diseases Hospital, China 236
Testing effectiveness (Phase 2)Ended earlyNCT00827099
What this trial is testing

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+2 more
Northside Hospital, Inc. 5
Testing effectiveness (Phase 2)UnknownNCT04997811
What this trial is testing

Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes (MDS)
Prof. Janet Dunn 120
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Early research (Phase 1)Ended earlyNCT00750334
What this trial is testing

Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Genzyme, a Sanofi Company 2
Early research (Phase 1)Active Not RecruitingNCT00710892
What this trial is testing

CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaMyelodysplastic Syndrome+1 more
Baylor College of Medicine 10
Next Page